Haemonetics (HAE)
(Delayed Data from NYSE)
$84.13 USD
+1.07 (1.29%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $84.13 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth C Momentum B VGM
Earnings News For HAE
-
Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand
-
Haemonetics: Fiscal Q4 Earnings Snapshot
-
Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates
-
Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
-
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
-
Haemonetics (HAE) Q3 Earnings Top Estimates, 2024 View Raised
-
Haemonetics (HAE) Surpasses Q3 Earnings and Revenue Estimates
-
Haemonetics: Fiscal Q3 Earnings Snapshot
-
Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
-
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?
-
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024
-
Haemonetics (HAE) Q2 Earnings Top Estimates, 2024 View Up
-
Haemonetics: Fiscal Q2 Earnings Snapshot
-
Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
-
Haemonetics (HAE) Reports Next Week: Wall Street Expects Earnings Growth
-
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023
-
Why Is Haemonetics (HAE) Down 1.9% Since Last Earnings Report?
-
Haemonetics (HAE) Q1 Earnings Top Estimates, 2024 View Up
-
Haemonetics (HAE) Surpasses Q1 Earnings and Revenue Estimates
-
Haemonetics: Fiscal Q1 Earnings Snapshot
-
Haemonetics 1st Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
-
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2024 Results: August 8, 2023
-
Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates
-
Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates
-
Haemonetics: Fiscal Q4 Earnings Snapshot